|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
      |
|||||||||||||
 |
 |
|||||||||||||
   
 |
||||||||||||||
Mission
Harness the Potential of Biomaterials for Soft Tissue Repair
Biomaterials are capable of addressing some of the most difficult challenges in the field of orthopedics. As we focus on new technologies to overcome the limitations of traditional treatment modalities, we are realizing higher levels of biocompatibility and distinct advantages over synthetic prostheses. With significant growth in the extremity and spine segment forecasted over the next five years, MiMedx is well positioned to deliver a comprehensive suite of orthopedics solutions.
Realizing our vision requires MiMedx to establish licensing arrangements to acquire, develop and commercialize promising technologies. This is a critical component in the process of taking our ideas forward.
These statements have not been reviewed by the FDA.
This website is not meant as a substitute for professional medical advice.
|
|
 |
|
